{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:45:35Z","timestamp":1790793935483,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejphar.2015.03.024","type":"journal-article","created":{"date-parts":[[2015,4,4]],"date-time":"2015-04-04T02:20:13Z","timestamp":1428114013000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity"],"prefix":"10.1016","volume":"757","author":[{"given":"Taro","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Kitaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoe","family":"Kassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.03.024_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","article-title":"Plasma and platelet excitatory amino acids in psychiatric disorders","volume":"150","author":"Altamura","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2004.08.015","article-title":"Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania","volume":"158","author":"Arban","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2015.03.024_bib3","first-page":"147","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib4","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/jm100736h","article-title":"Design, synthesis, and structure\u2013activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5","volume":"53","author":"Burdi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.03.024_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2015.03.024_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm025570j","article-title":"3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity","volume":"46","author":"Cosford","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.03.024_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","article-title":"Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression","volume":"5","author":"Detke","year":"1997","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2015.03.024_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"15","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00726-001-0130-6","article-title":"In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article","volume":"23","author":"Kuhn","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2015.03.024_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.03.024_bib12","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1016\/j.bmcl.2013.09.059","article-title":"Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators","volume":"23","author":"Kubas","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2015.03.024_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib14","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"137","key":"10.1016\/j.ejphar.2015.03.024_bib15","first-page":"215","article-title":"Ketamine and the potential role for rapid-acting antidepressant medications","volume":"2007","author":"Krystal","year":"2007","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ejphar.2015.03.024_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-007-0063-1","article-title":"The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects","volume":"9","author":"Maeng","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.ejphar.2015.03.024_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000026491","article-title":"Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment","volume":"37","author":"Mauri","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"30","key":"10.1016\/j.ejphar.2015.03.024_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"2006","author":"Mitani","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib22","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.95.5.2642","article-title":"Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting NMDA receptor-mediated calcium influx","volume":"95","author":"Nonaka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.03.024_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0091-3057(90)90377-T","article-title":"Inhibition by antimanic drugs of hyperactivity induced by methamphetamine\u2013chlordiazepoxide mixture in mice","volume":"35","author":"Okada","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2015.03.024_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","article-title":"Abnormal glutamatergic neurotransmission and neuronal\u2013glial interactions in acute mania","volume":"64","author":"Ong\u00fcr","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.pbb.2005.06.015","article-title":"Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist","volume":"81","author":"Pa\u0142ucha","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2015.03.024_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Pa\u0142ucha","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.03.024_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-013-3206-6","article-title":"The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent","volume":"231","author":"Pa\u0142ucha-Poniewiera","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0028-3908(02)00082-5","article-title":"Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats","volume":"43","author":"Pilc","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejphar.2015.03.024_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.024_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.03.024_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR\u204eD): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Controll. Clin. Trials"},{"key":"10.1016\/j.ejphar.2015.03.024_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1196\/annals.1300.018","article-title":"Clinical studies implementing glutamate neurotransmission in mood disorders","volume":"1003","author":"Sanacora","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2015.03.024_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-6147(93)90107-U","article-title":"Metabotropic glutamate receptors in brain function and pathology","volume":"14","author":"Schoepp","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"issue":"161","key":"10.1016\/j.ejphar.2015.03.024_bib35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuroscience.2009.04.013","article-title":"Glutamate-mediated calcium signaling: a potential target for lithium action","volume":"2009","author":"Sourial-Bassillious","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2015.03.024_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abio.1997.2308","article-title":"A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor","volume":"252","author":"Stables","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2015.03.024_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuropharm.2007.08.002","article-title":"Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent","volume":"53","author":"Stachowicz","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.03.024_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd1630","article-title":"Metabotropic glutamate receptors as novel targets for anxiety and stress disorders","volume":"4","author":"Swanson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2015.03.024_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u204eD: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.03.024_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152707780363302","article-title":"Metabotropic glutamate receptors in the control of mood disorders","volume":"6","author":"Witkin","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:00:16Z","timestamp":1747864816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":40,"alternative-id":["S0014299915002393"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}